Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
Journal of Consulting and Clinical Psychology
|
May 4, 1999
A test of behavioral family therapy to augment exposure for combat-related posttraumatic stress disorder
S M Glynn, S Eth, E T Randolph, et al.
Translational Psychiatry
|
January 22, 2019
Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats
S H Lee, C A Mastronardi, R W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer
Daniel D Karp, Luis G Paz-Ares, Silvia Novello, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 5, 2014
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
G V Scagliotti, C Gridelli, F de Marinis, et al.
Clinical Lung Cancer
|
May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Corey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2011
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumors
Luis G Paz-Ares, Carlos Gomez-Roca, Jean-Pierre Delord, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study
Cesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Food Science & Nutrition
|
August 18, 2025
Kombucha Prevents Indomethacin-Induced Enteric Damage in Wistar Rat by Enhancing Epithelial Gut Barrier and Modulating Gut Microbiota
Atziri A Varela-Mendoza, Ma Magdalena Martínez-Flores, Melanie G Paz-Jiménez, et al.
The Journal of Clinical Psychiatry
|
February 5, 2009
Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia
Luísa W Bisol, Miriam G Brunstein, Gustavo L Ottoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Cesare Gridelli, Filippo de Marinis, Jean-Louis Pujol, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
Journal of Consulting and Clinical Psychology
|
May 4, 1999
A test of behavioral family therapy to augment exposure for combat-related posttraumatic stress disorder
S M Glynn, S Eth, E T Randolph, et al.
Translational Psychiatry
|
January 22, 2019
Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats
S H Lee, C A Mastronardi, R W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer
Daniel D Karp, Luis G Paz-Ares, Silvia Novello, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 5, 2014
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
G V Scagliotti, C Gridelli, F de Marinis, et al.
Clinical Lung Cancer
|
May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Corey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2011
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumors
Luis G Paz-Ares, Carlos Gomez-Roca, Jean-Pierre Delord, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study
Cesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Food Science & Nutrition
|
August 18, 2025
Kombucha Prevents Indomethacin-Induced Enteric Damage in Wistar Rat by Enhancing Epithelial Gut Barrier and Modulating Gut Microbiota
Atziri A Varela-Mendoza, Ma Magdalena Martínez-Flores, Melanie G Paz-Jiménez, et al.
The Journal of Clinical Psychiatry
|
February 5, 2009
Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia
Luísa W Bisol, Miriam G Brunstein, Gustavo L Ottoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Cesare Gridelli, Filippo de Marinis, Jean-Louis Pujol, et al.
Page
of 19